Inspection Record

Neopharm Labs Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-12-09 6 findingsStability and storageComputer system validationDeviation, CAPA, and investigationRegulatory reporting and change controlEquipment and facilityContamination control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

The temperature and/or humidity control was inadequate.

2Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

3Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

4Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

5Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

6Contamination control

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-12-09. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Neopharm Labs Inc. findings history — including this company's other documents Health Canada documents, 2024 Go to Findings search